# First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

> **NCT00736814** · PHASE2 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 117 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** docetaxel
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00736814
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2011-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736814, "First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00736814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*